Tumor necrosis factor stimulates urokinase-type plasminogen activator and inhibitor type 1 production in A549 lung carcinoma cells: treatment of monolayer and tridimensional cultures.
Dosne
A M
AM
Lab. Immunopharmacologie Exp., UPR 405 CNRS, Hotel Dieu, Paris, France.
Beaupain
R
R
Samama
M
M
D002464:Cell Migration Inhibition; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism*; D015849:Plasminogen Inactivators / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000096:biosynthesis*
D005343:Fibrinolytic Agents; D015849:Plasminogen Inactivators; D014409:Tumor Necrosis Factor-alpha; D014568:Urokinase-Type Plasminogen Activator